Produktname:ethyl 2-((2-aminothiazol-5-yl)thio)acetate
IUPAC Name:ethyl 2-[(2-amino-1,3-thiazol-5-yl)sulfanyl]acetate
- CAS：859522-19-3
- Molekulare Formel：C7H10N2O2S2
- Reinheit：95%
- Katalognummer：CM132250
- Molekulargewicht：218.29
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:859522-19-3
- Molekulare Formel:C7H10N2O2S2
- Schmelzpunkt:-
- SMILES-Code:O=C(OCC)CSC1=CN=C(N)S1
- Dichte:
- Katalognummer:CM132250
- Molekulargewicht:218.29
- Siedepunkt:368.9°C at 760 mmHg
- Mdl-Nr.:
- Lagerung:Keep in dark place, store at 2-8°C.
Category Infos
- Thiazoles
- Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.
Column Infos
- Cadisegliatin
- vTv Therapeutics announces FDA submission for first phase 3 study of Cadisegliatin in patients with type 1 diabetes. Cadisegliatin (TTP399) is developed as an adjunctive therapy to insulin for the treatment of type 1 diabetes, and the phase 3 trial evaluates its safety and efficacy.
Glucokinase (GK) is mainly concentrated in liver cells, and involved in the regulation of glucose metabolism. Cadisegliatin (TTP399) is a liver-selective glucosekinase activator with a mechanism of action different from that of antidiabetic drugs. It binds to the allosteric site of GK and restores innate glucose-regulating capacity of the liver, not disrupting the interaction between GK and GKRP. Cadisegliatin previously received a Breakthrough Therapy designation from the U.S. FDA.
Suche 
+86 21 5895 0110 
